Literature DB >> 15115021

Insurance companies' access to genetic information: why regulation alone is not enough.

Niklas Juth1.   

Abstract

The background of this paper is the ongoing dismantling of the social insurance systems in favour of commercialisation and privatisation of insurances needed for illness, old age and premature death. This combined with the increased possibility of using genetic testing for differentiating personal insurance premiums has the potentiality of creating a 'genetic proletariat'--an uninsurable high-risk population. The common way of handling this problem in Sweden, and many other developed countries around the North Atlantic, has been to regulate insurance companies' right to ask for and use genetic information in various ways. There is a distinction between partial regulation (that allows insurance companies access to genetic information from genetic tests already made, sometimes only above a specified amount, but not to demand new tests) and total regulation (that forbids insurance companies to ask for or use any genetic information). I will argue that these forms of regulation probably will have adverse consequences given the dismantling of collective social insurance systems. If this is convincing, a better way to solve the problem of an uninsurable high-risk population (and other problems) is to resurrect the collective, obligatory insurance systems in which the individual risk profile does not constitute a basis for premium determination. Both arguments cast in terms of consequences and justice render support for this conclusion.

Entities:  

Keywords:  Analytical Approach; Genetics and Reproduction; Health Care and Public Health; Legal Approach

Mesh:

Year:  2003        PMID: 15115021     DOI: 10.1007/bf03351386

Source DB:  PubMed          Journal:  Monash Bioeth Rev        ISSN: 1321-2753


  7 in total

1.  Large upward bias in estimation of locus-specific effects from genomewide scans.

Authors:  H H Göring; J D Terwilliger; J Blangero
Journal:  Am J Hum Genet       Date:  2001-10-09       Impact factor: 11.025

2.  Genetic Catch-22: testing, risk and private health insurance.

Authors:  Adam Hedgecoe
Journal:  Bus Prof Ethics J       Date:  1996

3.  Individual, family, and societal dimensions of genetic discrimination: a case study analysis.

Authors:  Lisa N Geller; Joseph S Alper; Paul R Billings; Carol I Barash; Jonathan Beckwith; Marvin R Natowicz
Journal:  Sci Eng Ethics       Date:  1996-01       Impact factor: 3.525

4.  Discrimination as a consequence of genetic testing.

Authors:  P R Billings; M A Kohn; M de Cuevas; J Beckwith; J S Alper; M R Natowicz
Journal:  Am J Hum Genet       Date:  1992-03       Impact factor: 11.025

5.  The Human Genome Project, predictive testing and insurance contracts: ethical and legal responses.

Authors:  R Chadwick; C Ngwena
Journal:  Res Publica       Date:  1995

6.  Insurability and the HIV epidemic: ethical issues in underwriting.

Authors:  N Daniels
Journal:  Milbank Q       Date:  1990       Impact factor: 4.911

7.  Genetic information and life insurance: a proposal for an ethical European policy.

Authors:  P Sandberg
Journal:  Soc Sci Med       Date:  1995-06       Impact factor: 4.634

  7 in total
  1 in total

1.  For the Sake of Justice: Should We Prioritize Rare Diseases?

Authors:  Niklas Juth
Journal:  Health Care Anal       Date:  2017-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.